FDA.reportPublic FDA data

denosumab-mobz 120 MG in 1.7 ML Injection

RxCUI
2729323
RxNorm name
denosumab-mobz 120 MG in 1.7 ML Injection
Display name
denosumab-mobz 120 MG in 1.7 ML Injection
Full name
denosumab-mobz 120 MG in 1.7 ML Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:27

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761457Oziltusdenosumab-mobz351(k) InterchangeableRx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
f040a245-1be4-4962-a8b7-a13ee7fac707denosumab-mobz 120 MG in 1.7 ML Injection [PSN] · 1.7 ML denosumab-mobz 70 MG/ML Injection [SCD] · denosumab-mobz 120 MG per 1.7 ML Injection [SY] · denosumab-mobz 70 MG/ML per 1.7 ML Injection [SY]44These highlights do not include all the information needed to use OZILTUS safely and effectively. See full prescribing information for OZILTUS. OZILTUS ® (denosumab-mobz) injection, for subcutaneous use Initial U.S. Approval: 2010 OZILTUS (denosumab-mobz) is biosimilar* to XGEVA ® (denosumab)20251222